M3, Inc.
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Latest From M3, Inc.
Mecobalamin For ALS Among New Japan Recommendations
Japan has issued positive approval recommendations for 10 new drugs, including Catalyst’s Firdapse and Idorsia/Nxera’s Quviviq, as well as a global-first nod for mecobalamin in ALS.
Company Information
- Industry
- Services
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Email Company
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice